SIAU
RLAY icon

SB Investment Advisers (UK)’s Relay Therapeutics RLAY Stock Holding History

SB Investment Advisers (UK)’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$522M Hold
27,904,963
– – 6.81% 3
2026
Q1 		$278M Hold
27,904,963
– – 3.59% 3
2025
Q4 		$236M Hold
27,904,963
– – 2.36% 5
2025
Q3 		$146M Hold
27,904,963
– – 1.1% 5
2025
Q2 		$96.6M Hold
27,904,963
– – 0.77% 6
2025
Q1 		$73.1M Hold
27,904,963
– – 0.67% 8
2024
Q4 		$115M Hold
27,904,963
– – 1.01% 8
2024
Q3 		$198M Hold
27,904,963
– – 1.63% 7
2024
Q2 		$182M Hold
27,904,963
– – 1.68% 6
2024
Q1 		$232M Hold
27,904,963
– – 2.29% 6
2023
Q4 		$307M Hold
27,904,963
– – 2.73% 6
2023
Q3 		$235M Hold
27,904,963
– – 1.93% 6
2023
Q2 		$350M Hold
27,904,963
– – 2.67% 7
2023
Q1 		$460M Hold
27,904,963
– – 3.78% 5
2022
Q4 		$417M Hold
27,904,963
– – 3.48% 6
2022
Q3 		$624M Hold
27,904,963
– – 4.78% 4
2022
Q2 		$467M Hold
27,904,963
– – 3.71% 6
2022
Q1 		$835M Hold
27,904,963
– – 3.96% 6
2021
Q4 		$857M Hold
27,904,963
– – 2.5% 8
2021
Q3 		$880M Hold
27,904,963
– – 2.73% 6
2021
Q2 		$1.02B Hold
27,904,963
– – 2% 9
2021
Q1 		$965M Hold
27,904,963
– – 1.67% 7
2020
Q4 		$1.16B Hold
27,904,963
– – 4.67% 4
2020
Q3 		$1.19B Buy
+27,904,963
New +$1.06B 10.21% 3

Other funds holding RLAY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SB Investment Advisers (UK)'s RLAY Position: Q2 2026 in Review

SB Investment Advisers (UK) held its Relay Therapeutics (RLAY) position steady in Q2 2026 at 27,904,963 shares worth $522M. The position accounts for 6.81% of the portfolio, ranked #3.

SB Investment Advisers (UK) first reported a position in RLAY in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.19B in Q3 2020. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • SB Investment Advisers (UK) held 27,904,963 shares of Relay Therapeutics worth $522M as of Q2 2026.
  • SB Investment Advisers (UK) left its Relay Therapeutics share count unchanged in Q2 2026.
  • Relay Therapeutics made up 6.81% of SB Investment Advisers (UK)'s portfolio in Q2 2026, its #3 holding.
  • SB Investment Advisers (UK) first reported a position in Relay Therapeutics in Q3 2020 and has held it in 24 quarters since.
  • SB Investment Advisers (UK)'s Relay Therapeutics position peaked at $1.19B in Q3 2020.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on SB Investment Advisers (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.